These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis. Zhang M; Guo J; Li H; Zhou Y; Tian F; Gong L; Wang X; Li Z; Zhang W J Mol Neurosci; 2013 Jun; 50(2):317-23. PubMed ID: 23397576 [TBL] [Abstract][Full Text] [Related]
64. Surrogate therapeutic outcome measures in patients with myasthenia gravis. Zinman L; Baryshnik D; Bril V Muscle Nerve; 2008 Feb; 37(2):172-6. PubMed ID: 17918748 [TBL] [Abstract][Full Text] [Related]
65. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody. Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855 [TBL] [Abstract][Full Text] [Related]
66. Concentric and single fiber needle electrodes yield comparable jitter results in myasthenia gravis. Farrugia ME; Weir AI; Cleary M; Cooper S; Metcalfe R; Mallik A Muscle Nerve; 2009 May; 39(5):579-85. PubMed ID: 19260051 [TBL] [Abstract][Full Text] [Related]
67. Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis. Sciacca G; Reggio E; Mostile G; Nicoletti A; Drago F; Salomone S; Zappia M Neurol Sci; 2018 Feb; 39(2):341-345. PubMed ID: 29330628 [TBL] [Abstract][Full Text] [Related]
68. miR-30e-5p as predictor of generalization in ocular myasthenia gravis. Sabre L; Maddison P; Wong SH; Sadalage G; Ambrose PA; Plant GT; Punga AR Ann Clin Transl Neurol; 2019 Feb; 6(2):243-251. PubMed ID: 30847357 [TBL] [Abstract][Full Text] [Related]
70. Recording Fewer Than 20 Potential Pairs With SFEMG May Suffice for the Diagnosis of Myasthenia Gravis. Abraham A; Breiner A; Barnett C; Katzberg HD; Bril V J Clin Neurophysiol; 2017 Sep; 34(5):408-412. PubMed ID: 28650411 [TBL] [Abstract][Full Text] [Related]
71. Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis. Rao J; Li S; Wang X; Cheng Q; Ji Y; Fu W; Huang H; Shi L; Wu X Front Med (Lausanne); 2022; 9():851808. PubMed ID: 35755064 [TBL] [Abstract][Full Text] [Related]
72. Concentric-needle single-fiber electromyography for the diagnosis of myasthenia gravis. Benatar M; Hammad M; Doss-Riney H Muscle Nerve; 2006 Aug; 34(2):163-8. PubMed ID: 16642500 [TBL] [Abstract][Full Text] [Related]
73. Immunotherapy for ocular myasthenia gravis: an observational study in Japan. Narita T; Nakane S; Nagaishi A; Minami N; Niino M; Kawaguchi N; Murai H; Kira JI; Shimizu J; Iwasa K; Yoshikawa H; Hatanaka Y; Sonoo M; Shimizu Y; Matsuo H Ther Adv Neurol Disord; 2023; 16():17562864231163819. PubMed ID: 37051222 [TBL] [Abstract][Full Text] [Related]